# PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis

> **NCT07119918** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 5276 (estimated)

## Conditions studied

- Symptomatic Intracranial Atherosclerotic Stenosis

## Interventions

- **DRUG:** Recaticimab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07119918
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2029-12-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 5276 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07119918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07119918, "PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07119918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*